We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory committee is recommending that the agency fundamentally change the way it tests new contraceptives to focus on comparative drug studies.
Pfizer is making major changes in the way the company is run in an effort to drive down costs, increase revenue and enhance innovation, Pfizer announced at a meeting of its senior staff.
An analysis of 84 studies by HHS’ Agency for Healthcare Research and Quality (AHRQ) found no strong evidence that atypical antipsychotics are effective for many of the off-label uses for which they are commonly prescribed.
GlaxoSmithKline (GSK) will undertake a head-to-head study of its candidate to prevent cervical cancer against Merck’s drug Gardasil in an effort to sway the market, GSK said.
New guidance issued Dec. 6 by Health Canada describes the process for applying to the Therapeutic Products Directorate (TPD) for a patented drug for export to least-developed and developing countries under Canada’s Access to Medicines Regime (CAMR).
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) updated its pharmaceutical marketing practice guide, creating tougher restrictions on the gifts healthcare professionals can receive, the organization announced.